BRIEF-Evgen Pharma granted orphan drug designation for stabilised sulforaphane

* FDA granted company orphan drug designation for use of

stabilised sulforaphane for treatment of subarachnoid

haemorrhage

Source text for Eikon:

Further company coverage:

Read more